Status:
COMPLETED
Modulation of Visually Evoked Potentials by an Antidepressant
Lead Sponsor:
University Hospital Freiburg
Conditions:
Depression
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
12 normal healthy controls will be treated with 50 mg sertraline once daily for three weeks. Early amplitudes of visually evoked potentials will be examined at day 0, 10 and 21 and statistically compa...
Eligibility Criteria
Inclusion
- healthy individuals 18-65 years
Exclusion
- history of affective oder other psyhiatric disorder
- severe medical condition
- pregnancy or ineffective contraception
- active illicit drug use
Key Trial Info
Start Date :
December 1 2005
Trial Type :
INTERVENTIONAL
End Date :
January 1 2006
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT00263133
Start Date
December 1 2005
End Date
January 1 2006
Last Update
June 4 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dept. of Psychiatry, University of Freiburg
Freiburg im Breisgau, Germany, 79104